论文部分内容阅读
517例急性心肌梗死患者于起病后24小时内收入冠心监护室治疗,随机抽样分为两组观察链激酶的疗效。第一组264例为链激酶组,平均53.2岁,给予丙酮香豆素(Warfarin)20毫克口服及倍他米松4毫克静注,链激酶25万单位在30分钟内输入,继以每小时10万单位,持续17小时,再在48小时内给予肝素每天25000单位。第二组为对照组253例,平均53.1岁,仅用抗凝疗法,以肝素5000单位静注,再给以每天25000单位共两天。
517 cases of acute myocardial infarction patients within 24 hours after onset income coronary care treatment, randomized divided into two groups observed the efficacy of streptokinase. In the first group, 264 patients were streptokinase with an average of 53.2 years. Patients were given 20 mg oral warfarin and 4 mg betamethasone intravenously. 250,000 streptokinase units were injected within 30 minutes, followed by 10 hours per hour Thousand units, lasted 17 hours, and then within 48 hours to give heparin 25,000 units a day. The second group of 253 cases of control group, mean 53.1 years old, only anticoagulant therapy, intravenous injection of heparin 5000 units, and then given a total of 25,000 units a day for two days.